EPISODE · Mar 24, 2020 · 17 MIN
Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.
Embed this episode
NOW PLAYING
Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
0:00
17:13
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Clinical Reviews?
This episode is 17 minutes long.
When was this JAMA Clinical Reviews episode published?
This episode was published on March 24, 2020.
Can I download this JAMA Clinical Reviews episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!